maricann group
Cannabis
Ontario-based medical cannabis company Maricann Group Inc. (CSE:MARI) announced the results of its first-quarter of fiscal 2018 on Wednesday. The company saw a decline in revenue for the quarter, which only reached $600,591 CAD compared ... [Read]
Belgravia Capital
Cannabis
Toronto-based Belgravia Capital International (CSE:BLGVF) announced on Wednesday that it had completed its acquisition of the Canadian company R&D Pharma Corp. Belgravia Capital, who “[develops] new companies with a focus on the legal medical cannabis industry,” ... [Read]